Mountain Crest Acquisition CORP V 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
10-Q: Mountain Crest Acquisition Corp. V Q2 2026 Update: Delisting and Business Combination Uncertainty
Mountain Crest Acquisition Corp. V's Q2 2026 Form 10-Q reveals significant challenges, including Nasdaq delisting and continued uncertainty regarding its business combination, alongside a net loss for the period.
OTC.Pink
Mountain Crest Acquisition Corp. V reports Q1 2026 financials, detailing operational costs and progress towards a business combination.
OTC.Pink
Mountain Crest Acquisition Corp. V reported a net loss for Q3 2025, extended its business combination deadline to November 2026, and continues to address going concern issues and internal control weaknesses.
OTC.Pink
Mountain Crest Acquisition Corp. V, a delisted SPAC, reported increased net losses and significant related-party debt while pursuing a business combination with CUBEBIO by November 2025, raising substantial doubt about its going concern.
OTC.Pink
Mountain Crest Acquisition Corp. V reports a net loss for Q1 2025 and navigates delisting challenges while pursuing a business combination with CUBEBIO Co., Ltd.
OTC.Pink
Mountain Crest Acquisition Corp. V reported a net loss for the third quarter of 2024 and provided an update on its business combination agreement with CUBEBIO Co., Ltd.
OTC.Pink
Mountain Crest Acquisition Corp. V reports a net loss for the second quarter of 2024 and announces a business combination agreement with CUBEBIO Co., Ltd.
OTC.Pink
Mountain Crest Acquisition Corp. V released its first quarter 2024 financial results, showing a net loss of $25,537 and provided an update on its business combination plans.